Invention Grant
US09561271B2 Nanoemulsion respiratory syncytial virus (RSV) subunit vaccine
有权
纳米乳液呼吸道合胞病毒（RSV）亚单位疫苗
- Patent Title: Nanoemulsion respiratory syncytial virus (RSV) subunit vaccine
- Patent Title (中): 纳米乳液呼吸道合胞病毒（RSV）亚单位疫苗
-
Application No.: US13608317Application Date: 2012-09-10
-
Publication No.: US09561271B2Publication Date: 2017-02-07
- Inventor: Ali I. Fattom , Tarek Hamouda , Vira Bitko , James R. Baker, Jr.
- Applicant: Ali I. Fattom , Tarek Hamouda , Vira Bitko , James R. Baker, Jr.
- Applicant Address: US MI Ann Arbor
- Assignee: NanoBio Corporation
- Current Assignee: NanoBio Corporation
- Current Assignee Address: US MI Ann Arbor
- Agency: Foley & Lardner LLP
- Main IPC: A61K39/155
- IPC: A61K39/155 ; A61K9/107 ; A61K47/10 ; A61K47/18 ; A61K47/26 ; A61K47/44 ; A61K39/12 ; A61K39/00
Abstract:
The present application relates to the field of immunology, in particular, a vaccine composition of respiratory syncytial virus (RSV) surface proteins, Fusion (F) and Glycoprotein (G) proteins subunit vaccine preferentially mixed with the immune cell targeting and enhancer, nanoemulsion to induce a protective immune response and avoid vaccine-induce disease enhancement.
Public/Granted literature
- US20130064867A1 NANOEMULSION RESPIRATORY SYNCYTIAL VIRUS (RSV) SUBUNIT VACCINE Public/Granted day:2013-03-14
Information query
